Embedded Files
Pongthorn Narongroeknawin, MD
Contact address
Department of Microbiology, Phramongkutklao College of Medicine
317 Ratchawithi Road, Thung Phyathai, Ratchathewi, Bangkok, THAILAND 10400
Tel. +662-354-7980
FAX. +662-354-4330
Email: npongthorn@pcm.ac.th
Current position
Assistant Professor of Medicine
Head of Department of Microbiology
Military rank
Colonel
Education
1996 ▪️Doctor of Medicine, Chulalongkorn University, Bangkok, Thailand
2000 ▪️Diplomate, Thai Board of Internal Medicine, Prince of Songkhla University, Songkhla, Thailand
2002 ▪️Diplomate, Thai Board of Family Medicine, Royal College of Family Physicians of Thailand
2004 ▪️Diplomate, Thai Subspecialty Board of Rheumatology, Phramongkutklao Hospital and College of Medicine, Bangkok, Thailand
2009 ▪️Certificate, Postdoctoral Training in Clinical Immunology and Rheumatology, the University of Alabama at Birmingham, Alabama, USA
Postgraduate experience
1997 ‐ 2000 ▪️Internal Medicine Resident, Department of Medicine, Songkhlanakarind hospital, Prince of Songkhla University, Songkhla, Thailand
2002 ‐ 2004 ▪️Rheumatology Fellow, Division of Rheumatology, Department of Internal Medicine, Phramongkutklao Hospital, Bangkok, Thailand
2008 ‐ 2009 ▪️Postdoctoral Training, Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Alabama, USA
2005 ‐ 2015 ▪️Rheumatology Instructor, Division of Rheumatology, Department of Internal Medicine, Phramongkutklao Hospital, Thailand
2016 - 2019 ▪️Head, Division of Rheumatology, Department of Internal Medicine, Phramongkutklao Hospital, Thailand
2019 – 2024 ▪️Assistant Director, Medical Education, Phramongkutklao College of Medicine, Bangkok, Thailand
2022 – present▪️Head, Department of Microbiology, Phramongkutklao College of Medicine, Bangkok, Thailand
Publications
Niyompanichakarn S, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P, Leosuthamas P, Pakchotanon R. The Effect of Gradual Withdrawal Versus Maintenance of Low-Dose Glucocorticoid in Clinically Quiescent Systemic Lupus Erythematosus, a Pilot Double-Blind Randomised Controlled Trial. Musculoskeletal Care. 2025 Jun;23(2):e70083. doi: 10.1002/msc.70083. PMID: 40148251.
Puksun K, Pongchaiyakul C, Pakchotanon R, Narongroeknawin P, Leosuthamas P, Arunthanachaikul T, Chaiamnuay S. Comparison of different intervention thresholds for the treatment of glucocorticoid-induced osteoporosis: a cross-sectional study. BMC Rheumatol. 2025 Apr 2;9(1):38. doi: 10.1186/s41927-025-00488-w. PMID: 40176176; PMCID: PMC11963468.
Arunthanachaikul T, Osothsinlp S, Nivatwongs S, Narongroeknawin P. Prevalence and Intriguing Clinical Profiles of Autoimmune Inner Ear Diseases in Sudden Sensorineural Hearing Loss. Otol Neurotol. 2025 Feb 1;46(2):215-220. doi: 10.1097/MAO.0000000000004391. Epub 2024 Dec 11. PMID: 39663802.
Karoonkatima M, Narongroeknawin P, Chaiamnuay S, Asavatanabodee P, Pakchotanon R. Glucocorticoid Withdrawal Symptoms and Quality of Life in Patients with Systemic Lupus Erythematosus. Int J Rheumatol. 2023 Nov 10;2023:5750791. doi: 10.1155/2023/5750791. PMID: 38023806; PMCID: PMC10656199.
Chitpet P, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P, Leosuthamas P, Pakchotanon R. The effect of systemic lupus erythematosus (SLE) Disease Activity Score and SLE Disease Activity Index 2000-based remission states in patients with SLE on damage accrual. Int J Rheum Dis. 2023 Dec;26(12):2509-2516. doi: 10.1111/1756-185X.14949. Epub 2023 Oct 24. PMID: 37875327.
Saisirivechakun P, Mahakkanukrauh A, Pongchaiyakul C, Boonya-Ussadorn T, Narongroeknawin P, Pakchotanon R, Assavatanabodee P, Chaiamnuay S. Prevalence of low trabecular bone score and its association with disease severity and activity in patients with axial spondyloarthritis. Sci Rep. 2023 Sep 27;13(1):16258. doi: 10.1038/s41598-023-43321-5. PMID: 37758825; PMCID: PMC10533482.
Katchamart W, Kieattisaksopon S, Narongroeknawin P, Muangpaisan W, Varothai N. Risk Factors for Sarcopenia in Thai Patients with Rheumatoid Arthritis. Discov Med. 2023 Jun;35(176):436-443. doi: 10.24976/Discov.Med.202335176.44. PMID: 37272110.
Prawjaeng J, Leelahavarong P, Budtarad N, Pilasant S, Chanjam C, Katchamart W, Narongroeknawin P, Kitumnuaypong T. Cost-utility analysis of biologic disease-modifying antirheumatic drugs (bDMARDs), targeted synthetic DMARDs (tsDMARDs) and biosimilar DMARDs (bsDMARDs) combined with methotrexate for Thai rheumatoid arthritis patients with high disease activity. BMC Health Serv Res. 2023 May 31;23(1):561. doi: 10.1186/s12913-023-09595-1. PMID: 37259090; PMCID: PMC10230705.
Leosuthamas P, Narongroeknawin P, Chaiamnuay S, Asavatanabodee P, Pakchotanon R. Performance of systemic lupus erythematosus responder index for detecting clinician-rated responders in patients with active systemic lupus erythematosus. Int J Rheum Dis. 2023 Feb 17. doi: 10.1111/1756-185X.14606. Epub ahead of print. PMID: 36802112.
Chaiamnuay S, Jiemjit S, Songdechaphipat W, Narongroeknawin P, Pakchotanon R, Asavatanabodee P. Predictors of flare in rheumatoid arthritis patients with persistent clinical remission/low disease activity: Data from the TARAC cohort. Medicine (Baltimore). 2022 Aug 12;101(32):e29974. doi: 10.1097/MD.0000000000029974. PMID: 35960097; PMCID: PMC9371488.
Sun X, Li R, Cai Y, Al-Herz A, Lahiri M, Choudhury MR, Hidayat R, Suryana BPP, Kaneko Y, Fujio K, Van Hung N, Pandya S, Pang LK, Katchamart W, Sigdel KR, Paudyal B, Narongroeknawin P, Chevaisrakul P, Sun F, Lu Y, Ho C, Yeap SS, Li Z; APLAR RA SIG group. Clinical remission of rheumatoid arthritis in a multicenter real-world study in Asia-Pacific region. Lancet Reg Health West Pac. 2021 Aug 12;15:100240. doi: 10.1016/j.lanwpc.2021.100240. PMID: 34528015; PMCID: PMC8365438.
Katchamart W, Narongroeknawin P, Sukprasert N, Chanapai W, Srisomnuek A. Rate and causes of noncompliance with disease-modifying antirheumatic drug regimens in patients with rheumatoid arthritis. Clin Rheumatol. 2021 Apr;40(4):1291-1298. doi: 10.1007/s10067-020-05409-5. Epub 2020 Sep 21. PMID: 32955630.
Phaopraphat K, Ngamjanyaporn P, Narongroeknawin P, Kasitanon N, Katchamart W. Clinical manifestations, clinical course, and outcomes of immunoglobulin G4-related disease. Int J Rheum Dis. 2020 Nov;23(11):1468-1473. doi: 10.1111/1756-185X.13949. Epub 2020 Aug 18. PMID: 32808722.
Bupparenoo P, Pakchotanon R, Narongroeknawin P, Asavatanabodee P, Chaiamnuay S. Effect of Curcumin on Serum Urate in Asymptomatic Hyperuricemia: A Randomized Placebo-Controlled Trial. J Diet Suppl. 2021;18(3):248-260. doi: 10.1080/19390211.2020.1757798. Epub 2020 May 18. PMID: 32420786.
Katchamart W, Narongroeknawin P, Chanapai W, Thaweeratthakul P. Health-related quality of life in patients with rheumatoid arthritis. BMC Rheumatol. 2019 Aug 14;3:34. doi: 10.1186/s41927-019-0080-9. PMID: 31428740; PMCID:PMC6694487.
Katchamart W, Narongroeknawin P, Suppa-Udom B, Chanapai W, Srisomnuek A. Factors associated with and cutoff points for Patient Acceptable Symptom State (PASS) in rheumatoid arthritis. Clin Rheumatol. 2020 Mar;39(3):779-786. doi:10.1007/s10067-019-04860-3. Epub 2019 Dec 10. PMID: 31823142.
Intongkam S, Samakarnthai P, Pakchotanon R, Narongroeknawin P, Assavatanabodee P, Chaiamnuay S. Efficacy and Safety of Hepatitis B Vaccination in Rheumatoid Arthritis Patients Receiving Disease-Modifying Antirheumatic Drugs and/or Biologics Therapy. J Clin Rheumatol. 2019 Dec;25(8):329-334. doi:10.1097/RHU.0000000000000877. PMID: 31764493.
Ruksasakul R, Narongroeknawin P, Assavatanabodee P, Chaiamnuay S. Group B streptococcus is the most common pathogen for septic arthritis with unique clinical characteristics: data from 12 years retrospective cohort study. BMC Rheumatol. 2019 Sep 16;3:38. doi: 10.1186/s41927-019-0084-5. PMID: 31535078; PMCID: PMC6745788.
Yongchairat K, Tanboon J, Waisayarat J, Narongroeknawin P, Chevaisrakul P, Dejthevaporn C, Katchamart W. Clinical spectrums and outcomes of necrotizing autoimmune myopathy versus other idiopathic inflammatory myopathies: a multicenter case-control study. Clin Rheumatol. 2019 Dec;38(12):3459-3469. doi: 10.1007/s10067-019-04756-2. Epub 2019 Aug 24. PMID: 31446540.
Katchamart W, Narongroeknawin P, Chanapai W, Thaweeratthakul P, Srisomnuek A. Prevalence of and factors associated with depression and anxiety in patients with rheumatoid arthritis: A multicenter prospective cross-sectional study. Int J Rheum Dis. 2020 Mar;23(3):302-308. doi: 10.1111/1756-185X.13781. Epub 2020 Jan 6. PMID: 31908153.
Poomsalood N, Narongroeknawin P, Chaiamnuay S, Asavatanabodee P, Pakchotanon R. Prolonged clinical remission and low disease activity statuses are associated with better quality of life in systemic lupus erythematosus. Lupus. 2019 Sep;28(10):1189-1196. doi: 10.1177/0961203319862614. Epub 2019 Jul 15. PMID: 31307256.
Katchamart W, Narongroeknawin P, Phutthinart N, Srinonprasert V, Muangpaisan W, Chaiamnauy S. Disease activity is associated with cognitive impairment in patients with rheumatoid arthritis. Clin Rheumatol. 2019 Jul;38(7):1851-1856. doi: 10.1007/s10067-019-04488-3. Epub 2019 Mar 8. PMID: 30848400.
Taibanguay N, Chaiamnuay S, Asavatanabodee P, Narongroeknawin P. Effect of patient education on medication adherence of patients with rheumatoid arthritis: a randomized controlled trial. Patient Prefer Adherence. 2019 Jan 11;13:119-129. doi: 10.2147/PPA.S192008. PMID: 30666095; PMCID: PMC6333161.
Chiowchanwisawakit P, Katchamart W, Osiri M, Narongroeknawin P, Chevaisrakul P, Kitumnuaypong T, Siripaitoon B, Louthrenoo W. Effectiveness and Drug Survival of Anti-Tumor Necrosis Factor α Therapies in Patients With Spondyloarthritis: Analysis From the Thai Rheumatic Disease Prior Authorization Registry. J Clin Rheumatol. 2019 Jan;25(1):9-15. doi: 10.1097/RHU.0000000000000741. PMID: 29517554.
Narongroeknawin P, Chevaisrakul P, Kasitanon N, Kitumnuaypong T, Mahakkanukrauh A, Siripaitoon B, Katchamart W; Thai Rheumatism Association. Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry. Int J Rheum Dis. 2018 Jan;21(1):170-178. doi: 10.1111/1756-185X.12937. Epub 2016 Nov 5. PMID: 28737837.
Louthrenoo W, Kasitanon N, Katchamart W, Aiewruengsurat D, Chevaisrakul P, Chiowchanwisawakit P, Dechanuwong P, Hanvivadhanakul P, Mahakkanukrauh A, Manavathongchai S, Muangchan C, Narongroeknawin P, Phumethum V, Siripaitoon B, Suesuwan A, Suwannaroj S, Uea-Areewongsa P, Ukritchon S, Asavatanabodee P, Koolvisoot A, Nanagara R, Totemchokchyakarn K, Nuntirooj K, Kitumnuaypong T. 2016 updated Thai Rheumatism Association Recommendations for the use of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis. Int J Rheum Dis. 2017 Sep;20(9):1166-1184. doi: 10.1111/1756-185X.13130. Epub 2017 Jul 21. PMID: 28730640.
Katchamart W, Narongroeknawin P, Chevaisrakul P, Dechanuwong P, Mahakkanukrauh A, Kasitanon N, Pakchotanon R, Sumethkul K, Ueareewongsa P, Ukritchon S, Bhurihirun T, Duangkum K, Intapiboon P, Intongkam S, Jangsombatsiri W, Jatuworapruk K, Kositpesat N, Leungroongroj P, Lomarat W, Petcharat C, Sittivutworapant S, Suebmee P, Tantayakom P, Tipsing W, Asavatanabodee P, Chiowchanwisawakit P, Foocharoen C, Koolvisoot A, Louthrenoo W, Siripaitoon B, Totemchokchyakarn K, Kitumnuaypong T; Thai Rheumatism Association. Evidence- based recommendations for the diagnosis and management of rheumatoid arthritis for non-rheumatologists: Integrating systematic literature research and expert opinion of the Thai Rheumatism Association. Int J Rheum Dis. 2017 Sep;20(9):1142-1165. doi: 10.1111/1756-185X.12905. Epub 2016 Jul 25. PMID: 27452207.
Siricheepchaiyan W, Narongroeknawin P, Pakchotanon R, Asavatanabodee P, Chaiamnuay S. Lupus Damage and Waist Circumference as the Independent Risk Factors for Cardiovascular Disease in SLE Patients from Phramongkutklao Hospital. J Med Assoc Thai. 2016 Mar;99(3):290-300. PMID: 27276740.
Paosong S, Narongroeknawin P, Pakchotanon R, Asavatanabodee P, Chaiamnuay S. Serum procalcitonin as a diagnostic aid in patients with acute bacterial septic arthritis. Int J Rheum Dis. 2015 Mar;18(3):352-9. doi: 10.1111/1756-185X.12496. Epub 2014 Dec 3. PMID: 25469944.
Darawankul B, Chaiamnuay S, Pakchotanon R, Asavatanabodee P, Narongroeknawin P. The good EULAR response at the first year is strongly predictive of clinical remission in rheumatoid arthritis: results from the TARAC cohort. Clin Rheumatol. 2015 Jan;34(1):43-9. doi: 10.1007/s10067-014-2749-1. Epub 2014 Jul 26. PMID: 25060487.
Kittiyanpanya C, Chaiamnuay S, Asavatanabodee P, Narongroeknawin P. Reliability and validity of the Thai version of bath ankylosing spondylitis indices. J Med Assoc Thai. 2014 Apr;97(4):381-5. PMID: 24964679.
Pakchotanon R, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P. The association between serum vitamin D Level and disease activity in Thai rheumatoid arthritis patients. Int J Rheum Dis. 2016 Apr;19(4):355-61. doi: 10.1111/1756-185X.12222. Epub 2013 Nov 13. PMID: 24219063.
Chaiamnuay S, Lomaratana V, Sumransurp S, Phukongchai S, Narongroeknawin P, Asavatanabodee P. Health-related quality of life and disease severity of SLE patients in Phramongkutklao Hospital. J Med Assoc Thai. 2010 Nov;93 Suppl 6:S125-30. PMID: 21280525.
Narongroeknawin P, Patkar NM, Shakoory B, Jain A, Curtis JR, Delzell E, Lander PH, Lopez-Ben RR, Pitt MJ, Safford MM, Volgas DA, Saag KG. Validation of diagnostic codes for subtrochanteric, diaphyseal, and atypical femoral fractures using administrative claims data. J Clin Densitom. 2012 Jan-Mar;15(1):92-102. doi: 10.1016/j.jocd.2011.09.001. Epub 2011 Nov 9. PMID: 22071028; PMCID: PMC4112756.
Chaiamnuay S, Chailurkit LO, Narongroeknawin P, Asavatanabodee P, Laohajaroensombat S, Chaiamnuay P. Current daily glucocorticoid use and serum creatinine levels are associated with lower 25(OH) vitamin D levels in Thai patients with systemic lupus erythematosus. J Clin Rheumatol. 2013 Apr;19(3):121-5. doi: 10.1097/RHU.0b013e318289bd16. PMID: 23519176.
Curtis JR, Arora T, Narongroeknawin P, Taylor A, Bingham CO 3rd, Cush J, Saag KG, Safford M, Delzell E. The delivery of evidence-based preventive care for older Americans with arthritis. Arthritis Res Ther. 2010;12(4):R144. doi: 10.1186/ar3086. Epub 2010 Jul 16. PMID: 20637072; PMCID: PMC2945038.
Narongroeknawin P, Danila MI, Humphreys LG Jr, Barasch A, Curtis JR. Bisphosphonate-associated osteonecrosis of the jaw, with healing after teriparatide: a review of the literature and a case report. Spec Care Dentist. 2010 Mar-Apr;30(2):77-82. doi: 10.1111/j.1754-4505.2009.00128.x. PMID: 20415805; PMCID: PMC4097110.
Curtis JR, Chen L, Harrold LR, Narongroeknawin P, Reed G, Solomon DH. Physician preference motivates the use of anti-tumor necrosis factor therapy independent of clinical disease activity. Arthritis Care Res (Hoboken). 2010 Jan 15;62(1):101-7. doi: 10.1002/acr.20020. PMID: 20191497; PMCID: PMC2913388.
Uea-areewongsa P, Chaiamnuay S, Narongroeknawin P, Asavatanabodee P. Factors associated with osteonecrosis in Thai lupus patients: a case control study. J Clin Rheumatol. 2009 Oct;15(7):345-9. doi: 10.1097/RHU.0b013e3181ba3423. PMID: 20009970.
Page updated
Google Sites
Report abuse